However, β blockers do not all share the same clinical outcomes with respect to efficacy or safety in many of these conditions. This is especially true in HF, where differences in reverse ...

carvedilol may be beneficial in patients in whom progression of symptoms or decline in EF occurs despite adequate therapy with maximally tolerated doses of another β blocker along with ACE ...